Cargando…

Integrating oral PrEP delivery among African women in a large HIV endpoint‐driven clinical trial

INTRODUCTION: Global guidelines emphasize the ethical obligation of investigators to help participants in HIV‐endpoint trials reduce HIV risk by offering an optimal HIV prevention package. Oral pre‐exposure prophylaxis (PrEP) has increasingly become part of state‐of‐the‐art HIV prevention. Here we d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beesham, Ivana, Welch, Julia D, Heffron, Renee, Pleaner, Melanie, Kidoguchi, Lara, Palanee‐Phillips, Thesla, Ahmed, Khatija, Baron, Deborah, Bukusi, Elizabeth A, Louw, Cheryl, Mastro, Timothy D, Smit, Jennifer, Batting, Joanne R, Malahleha, Mookho, Bailey, Veronique C, Beksinska, Mags, Donnell, Deborah, Baeten, Jared M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217491/ https://www.ncbi.nlm.nih.gov/pubmed/32396700 http://dx.doi.org/10.1002/jia2.25491

Ejemplares similares

Incorporating oral PrEP into standard prevention services for South African women: a nested interrupted time-series study
por: Donnell, Deborah, et al.
Publicado: (2021)

Exploring the Use of Oral Pre-exposure Prophylaxis (PrEP) Among Women from Durban, South Africa as Part of the HIV Prevention Package in a Clinical Trial
por: Beesham, Ivana, et al.
Publicado: (2020)

Sexual Behaviors After PrEP Discontinuation Among HIV Serodiscordant Couples in Kenya and Uganda
por: Stalter, Randy, et al.
Publicado: (2020)

Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial
por: Beesham, Ivana, et al.
Publicado: (2022)

Hepatitis B virus reactivation or reinfection in a FEM-PrEP participant: a case report
por: Malahleha, Mookho, et al.
Publicado: (2015)

Adherence to recommendations for ART and targeted PrEP use among HIV serodiscordant couples in East Africa: the “PrEP as a bridge to ART” strategy
por: Musinguzi, Nicholas, et al.
Publicado: (2020)

Uptake of Contraception Among Adolescent Girls and Young Women PrEP Clients: Leveraging the Opportunity to Strengthen HIV and Sexual and Reproductive Health Integration
por: Pleaner, Melanie, et al.
Publicado: (2021)

Sexually transmitted infections among women randomised to depot medroxyprogesterone acetate, a copper intrauterine device or a levonorgestrel implant
por: Deese, Jennifer, et al.
Publicado: (2021)

Brief Report: Quantifiable Plasma Tenofovir Among South African Women Using Daily Oral Pre-exposure Prophylaxis During the ECHO Trial
por: Beesham, Ivana, et al.
Publicado: (2022)

Pharmacy delivery to expand the reach of PrEP in Africa
por: Ortblad, Katrina F, et al.
Publicado: (2020)

Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions
por: Ndase, Patrick, et al.
Publicado: (2015)

Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression
por: Morrison, Charles S., et al.
Publicado: (2020)

Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial
por: Beksinska, Mags, et al.
Publicado: (2021)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

High HIV incidence among young women in South Africa: Data from a large prospective study
por: Palanee-Phillips, Thesla, et al.
Publicado: (2022)

“PrEP Gives the Woman the Control”: Healthcare Worker Perspectives on Using pre-Exposure Prophylaxis (PrEP) During Pregnancy and Postpartum in Kenya
por: Mwongeli, Nancy, et al.
Publicado: (2022)

1287. PrEP-Engaged or PrEP Curious?: A Characterization and Comparison of Initial PrEP Appointment Attenders vs. Nonattenders
por: Kahal, Deborah A, et al.
Publicado: (2019)

High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study
por: Beesham, Ivana, et al.
Publicado: (2022)

Age-Specific Risk Scores Do Not Improve HIV-1 Prediction Among Women in South Africa
por: Peebles, Kathryn, et al.
Publicado: (2020)

Patterns of PrEP continuation and coverage in the first year of use: a latent class analysis of a programmatic PrEP trial in Kenya
por: Mugwanya, Kenneth K., et al.
Publicado: (2023)

No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda
por: Ortblad, Katrina F., et al.
Publicado: (2019)

Response to “Oral PrEP for young African women and men”
por: Celum, Connie L, et al.
Publicado: (2016)

Effect of Depression on Adherence to Oral PrEP Among Men and Women in East Africa
por: Velloza, Jennifer, et al.
Publicado: (2018)

Uptake and impact of facility‐based HIV self‐testing on PrEP delivery: a pilot study among young women in Kisumu, Kenya
por: Wanga, Valentine, et al.
Publicado: (2020)

PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
por: Celum, Connie L., et al.
Publicado: (2022)

PrEP as a Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan Africa
por: Haberer, Jessica E., et al.
Publicado: (2019)

Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials
por: Agot, Kawango, et al.
Publicado: (2014)

The importance of PrEP persistence in preventing HIV infections on PrEP
por: Spinelli, Matthew A, et al.
Publicado: (2020)

Post-trial access to and use of pre-exposure prophylaxis in Durban, South Africa
por: Beesham, Ivana, et al.
Publicado: (2023)

Facilitators of Adherence to the Study Pill in the FEM-PrEP Clinical Trial
por: Corneli, Amy, et al.
Publicado: (2015)

Response to “Being prepared to evaluate pregnancy PrEP”
por: Dettinger, Julia C, et al.
Publicado: (2019)

“PrEP”ing for a PrEP demonstration project: understanding PrEP knowledge and attitudes among cisgender women
por: Pasipanodya, Elizabeth C., et al.
Publicado: (2021)

Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in women
por: Donnell, Deborah, et al.
Publicado: (2023)

PrEP-RN: Clinical Considerations and Protocols for Nurse-Led PrEP
por: O'Byrne, Patrick, et al.
Publicado: (2019)

Predictors of PrEP awareness, PrEP discussion and interest in long‐acting injectable PrEP among Filipina transfeminine adults
por: Restar, Arjee Javellana, et al.
Publicado: (2023)

Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP
por: Corneli, Amy, et al.
Publicado: (2015)

Rethinking HIV prevention to prepare for oral PrEP implementation for young African women
por: Celum, Connie L, et al.
Publicado: (2015)

Development of a relationship counselling website to identify and mitigate risk of intimate partner violence in the context of women’s PrEP use
por: Hartmann, Miriam, et al.
Publicado: (2023)

Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP
por: van Dijk, Mart, et al.
Publicado: (2021)

Integrating PrEP into HIV care clinics could improve partner testing services and reinforce mutual support among couples: provider views from a PrEP implementation project in Kenya
por: Odoyo, Josephine B, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o7g3e9fme0v63f1nch0rji5d6j